Health Legislation Amendment Act 1986 (Cth)
PART I—PRELIMINARY
Section
1. Short title
2. Commencement
PART II—AMENDMENTS OF HEALTH INSURANCE ACT 1973
3. Principal Act
4. Interpretation
5. Insertion of new section—
3aaa. Approved pathology practitioners to carry out pathology services or to supervise pathology services personally
6. Health services not specified in an item
7. Variations and alterations of general medical services table
8. Minister may vary pathology services table
9. Multiple pathology services
10. Insertion of new sections—
4ba. Pathologist-determinable services
4bb. Prescribed pathology services
4bc. Manner of making determinations under sections 4a, 4ba and 4bb
11. Interpretation
12. Increased fee in complex cases
13. Appeal from decision on increased fee
14. Medicare benefit in respect of 2 or more operations
15. Repeal of sections 16a, 16b and 16c and substitution of new section—
16a. Medicare benefits in relation to pathology services
16. Regulations may provide that medicare benefit not be payable in respect of a prescribed class of professional services
17. Medicare benefit not payable in respect of services rendered by disqualified practitioners, &c.
18. Assignment of medicare benefit
TABLE OF PROVISIONS—
Section
19. Insertion of new Part—
PART IIa—SPECIAL PROVISIONS RELATING TO PATHOLOGY
23da. Interpretation
23db. Forms of undertaking
23dc. Giving and acceptance of approved pathology practitioner undertaking
23dd. Period of effect of approved pathology practitioner undertaking
23de. Approved pathology practitioner may terminate undertaking
23df. Giving and acceptance of approved pathology authority undertaking
23dg. Period of effect of approved pathology authority undertaking
23dh. Approved pathology authority may terminate undertaking
23dj. Repayment of fee
23dk. Request forms and confirmation forms
23dl. Breaches of undertakings by approved pathology practitioners and approved pathology authorities
23dm. Initiation of excessive pathology services
23dn. Accredited pathology laboratories
23do. Review of decisions
23dp. Offences in relation to request forms and confirmation forms
20. Functions of Committee
21. Insertion of new Division—
78a. Interpretation
78b. Establishment of Pathology Services Advisory Committee
78c. Functions of Committee
78d. Constitution of Committee
78e. Remuneration and allowances
78f. Resignation
78g. Leave of absence
78h. Termination of appointment
78j. Acting appointments
78k. Meetings of Committee
78l. Proceedings at meetings
22. Interpretation
23. Members of Committees under the National Health Act may be deemed to be members of Committees under this Division
24. Repeal of section 82 and substitution of new section—
82. Functions of Committees
25. Hearing by Committee
26. Notice to practitioner or other person of hearing
27. Report by Committee
28. Recommendation by Committee
29. Determination by Minister
30. Interpretation
31. References and applications to Tribunal or Court
32. Proceedings on review
TABLE OF PROVISIONS—
Section
33. Interpretation
34. Chairperson, &c., to be notified if practitioner convicted of relevant offence
35. Chairperson to establish Medicare Participation Review Committee
36. Determinations in relation to relevant offences
37. Insertion of new sections—
124fa. Committee may add parties to proceedings in relation to breach of undertaking by approved pathology practitioner or approved pathology authority
124fb. Determinations in relation to breach of undertaking by approved pathology practitioner
124fc. Determinations in relation to breach of undertaking by approved pathology authority
124fd. Committee may be established and proceedings may continue after undertaking ceases to be in force
124fe. Committee may add parties to proceedings in relation to initiation of excessive pathology services
124ff. Determinations in relation to initiation of excessive pathology services
38. Hearings
39. Guidelines relating to making of determinations
40. Procedure of hearings
41. Chairperson to give notice of determinations by Committee
42. Review by Administrative Appeals Tribunal
43. Giving effect to determinations
44. Chairperson to abolish Committee
45. False statements relating to medicare benefits, &c.
46. Knowingly making false statements relating to medicare benefits, &c.
47. Bribery, &c.
48. Prohibited practices in relation to rendering of pathology services
49. Recovery of amounts
50. Delegation
51. Amendment of Schedule
52. New Schedule 1a to Principal Act
53. Minor amendments
54. Saving of certain proceedings
PART III—AMENDMENTS OF HEALTH INSURANCE COMMISSION ACT 1973
55. Principal Act
56. Borrowing and investment
PART IV—AMENDMENTS OF NATIONAL HEALTH ACT 1953
57. Principal Act
58. Interpretation
59. Interpretation
60. Limited charges for pharmaceutical benefits
61. Interpretation
62. Repeal of heading and substitution of new heading
63. Medical Services Federal Committee of Inquiry (Pharmaceutical Benefits)
64. Functions of Federal Committee
65. Medical Services State Committees of Inquiry (Pharmaceutical Benefits)
66. Functions of State Committees
67. Medical consultants
68. Functions of Federal Committee
69. Functions of State Committee
70. Minor amendments
71. Savings
TABLE OF PROVISIONS—
Section
PART V—AMENDMENTS OF STATES GRANTS (NURSE EDUCATION TRANSFER ASSISTANCE) ACT 1985
72. Principal Act
73. Special nurse education transfer grants
PART VI—AMENDMENTS OF TUBERCULOSIS ACT 1948
74. Principal Act
75. Advisory Council
SCHEDULE 1
NEW SCHEDULE 1a TO HEALTH INSURANCE ACT 1973
SCHEDULE 2
MINOR AMENDMENTS OF HEALTH INSURANCE ACT 1973
SCHEDULE 3
MINOR AMENDMENTS OF NATIONAL HEALTH ACT 1953
[
BE IT ENACTED by the Queen, and the Senate and the House of Representatives of the Commonwealth of Australia, as follows:
(a) by inserting after the definition of “accredited dental practitioner” in sub-section (1) the following definition:
“ ‘accredited pathology laboratory’ means premises in respect of which there is in force an approval under section 23dn;”;
(b) by omitting from sub-section (1) the definition of “approved pathology practitioner” and substituting the following definitions:
“ ‘approved pathology authority’ means a person in respect of whom there is in force an undertaking given by the person, and accepted by the Minister, under section 23df;
‘approved pathology practitioner’ means a person in respect of whom there is in force an undertaking given by the person, and accepted by the Minister, under section 23dc;”;
(c) by inserting after the definition of “eligible person” in sub-section (1) the following definition:
“ ‘excessive pathology service’ means a pathology service—
(a) in respect of which medicare benefit has become or may become payable; and
(b) that is not reasonably necessary for the adequate medical or dental care of the patient concerned;”;
(d) by inserting after the definition of “hospital treatment” in sub-section (1) the following definition:
“ ‘initiate’, in relation to a pathology service, means make the decision by reason of which the service is rendered;”;
(e) by inserting after the definition of “participating optometrist” in sub-section (1) the following definition:
“ ‘pathologist-determinable service’ means a pathology service specified, or a pathology service included in a class of pathology services specified, in a determination in force under section 4ba;”;
(f) by omitting from sub-section (1) the definition of “prescribed pathology service” and substituting the following definition:
“ ‘prescribed pathology service’ means a pathology service specified, or a pathology service included in a class of pathology services specified, in a determination in force under section 4bb;”; and
(g) by omitting “, within the meaning of section 16a,” from paragraph (d) of the definition of “professional service” in sub-section (1).
(a) by omitting “wife” from sub-paragraph (aa) (i) of the definition of “dependant” in sub-section (1) and substituting “spouse”;
(b) by omitting “wife or husband” from sub-paragraph (aa) (ii) of the definition of “dependant” in sub-section (1) and substituting “spouse”;
(c) by omitting “wife or husband” from sub-sub-paragraph (aa) (iii) (d) of the definition of “dependant” in sub-section (1) and substituting “spouse”; and
(d) by omitting sub-section (10a).
(a) by inserting after the definition of “friendly society” in sub-section (1) the following definition:
“ ‘general medical services table’ means the table of medical services set out in Schedule 1;”;
(b) by omitting from sub-section (1) the definition of “pathology service” and substituting the following definitions:
“ ‘pathology service’ means a medical service to which an item of the pathology services table relates;
‘pathology services table’ means the table of medical services set out in Schedule 1a;”;
(c) by omitting from sub-section (1) the definition of “table” and substituting the following definition:
“ ‘table’ means the table consisting of the general medical services table and the pathology services table.”; and
(d) by inserting in sub-section (5) “general medical services” before “table”.
“3aaa. (1) For the purposes of this Act, a pathology service shall not be taken to be rendered on behalf of an approved pathology practitioner unless the service is rendered under the personal supervision of the approved pathology practitioner.
“(2) For the purposes of this Act, a pathology service shall not be taken to be rendered under the personal supervision of an approved pathology practitioner unless the approved pathology practitioner—
(a) exercises a reasonable level of personal control over the rendering of the service; and
(b) has personal responsibility for the proper rendering of the service.”.
(a) by inserting in sub-section (1) “general medical services” before “table” (first occurring); and
(b) by inserting in sub-section (2) “(other than pathology services)” after “services”.
(a) by omitting from sub-section (1) “Medicare Benefits Advisory Committee” and substituting “Pathology Services Advisory Committee”;
(b) by omitting from sub-section (1) “table” and substituting “pathology services table (including a table that has effect by virtue of paragraph (9) (a))”;
(c) by omitting from sub-section (2) “table” and substituting “pathology services table (including a table that has effect by virtue of paragraph (9) (a))”;
(d) by omitting from paragraph (2) (a) “Part 7” and substituting “the table”;
(e) by omitting from sub-section (2) “that Part” (wherever occurring) and substituting “the table”;
(f) by inserting in sub-section (3) “pathology services” before “table” (first occurring);
(g) by omitting sub-section (4) and substituting the following sub-section:
“(4) If the Pathology Services Advisory Committee, otherwise than pursuant to a reference to it under sub-section (1), recommends to the Minister a variation of the pathology services table, the Minister may make a determination varying the table in accordance with the recommendation.”;
(h) by omitting from sub-section (5) “this section” (first occurring) and substituting “sub-section (3) or (4)”;
(j) by inserting in sub-section (5) “pathology services” before “table”; and
(k) by omitting sub-sections (6), (7), (8) and (9) and substituting the following sub-sections:
“(6) The Minister may refer to the Pathology Services Advisory Committee, for its consideration and recommendation, the question whether the table specified in the reference should be substituted for the pathology services table.
“(7) If, after consideration of a question referred to it under sub-section (6), the Committee recommends to the Minister that a table, whether or not the table specified in the reference by the Minister, be substituted for the pathology services table, the Minister may make a determination, in accordance with the recommendation, that the table specified in the determination be substituted for the pathology services table.
“(8) If the Pathology Services Advisory Committee, otherwise than pursuant to a reference to it under sub-section (6), recommends to the Minister that a table be substituted for the pathology services table, the Minister may make a determination, in accordance with the recommendation, that the table specified in the determination be substituted for the pathology services table.
“(9) Upon the coming into effect of a determination made under sub-section (7) or (8)—
(a) the table specified in the determination has effect as if it were set out in Schedule 1ain place of the table (in this sub-section referred to as the ‘superseded table’) in that Schedule; and
(b) the superseded table or, if another table has effect, by virtue of this section, in place of the superseded table, that other table ceases to have effect.”.
(a) by omitting from sub-section (1) “sections 4 and” and substituting “section”;
(b) by omitting from sub-section (2) “regulation for the purposes of section 4 or a”; and
(c) by inserting in sub-section (3) “pathology services” before “table”.
“4ba. The Minister may, after consulting the Royal College of Pathologists of Australasia, determine, in writing, that—
(a) a pathology service specified in the determination is a pathologist-determinable service for the purposes of this Act; or
(b) pathology services included in a class of pathology services specified in the determination are pathologist-determinable services for the purposes of this Act.
“4bb. The Minister may determine, in writing, that—
(a) a pathology service specified in the determination is a prescribed pathology service for the purposes of this Act; or
(b) pathology services included in a class of pathology services specified in the determination are prescribed pathology services for the purposes of this Act.
“4bc. (1) In this section, ‘relevant determination’ means a determination under section 4a, 4ba or 4bb.
“(2) Sections 48, 49, 49a and 50 of the
“(3) Relevant determinations shall not be taken to be statutory rules within the meaning of the
“(4) For the purposes of the application of sub-section 5 (3b) of the
“(5) Section 5 of the
(a) by inserting in sub-section (2) “the professional service referred to in the claim is a service other than a pathology service and” after “Where”;
(b) by omitting from sub-section (2) “referred to in the claim”;
(c) by inserting after sub-section (2) the following sub-section:
“(2a) Where the professional service referred to in the claim is a pathology service and the Commission considers that the professional service is of unusual length or complexity, the Commission shall—
(a) if the Commission considers that the service is of a kind in respect of which an increased fee may be fixed in accordance with principles furnished to the Commission under paragraph (b) of this sub-section or under sub-section 12 (5)—fix an increased fee for that service, in accordance with those principles, for the purposes of this section; or
(b) in any other case—refer to the Pathology Services Advisory Committee for its consideration and recommendation the question whether the fee specified in the item that relates to that service should, for the purpose of calculating the medicare benefit in respect of the service, be increased, having regard to the unusual features of that service, and, if it is to be increased, what principles are to be followed in fixing the amount of the increased fee for that service for the purposes of this section.”; and
(d) by omitting from sub-section (3) “of the Committee under paragraph (2) (b)” and substituting “under paragraph (2) (b) or (2a) (b)”.
(a) by omitting from sub-section (2) “Medicare Benefits Advisory Committee” and substituting “relevant committee”;
(b) by omitting from sub-section (3) “Committee” and substituting “relevant committee”;
(c) by omitting from sub-section (4) “Committee” (wherever occurring) and substituting “relevant committee”;
(d) by omitting from sub-section (6) “Medicare Benefits Advisory Committee” and substituting “relevant committee”;
(e) by omitting from sub-section (6) “Committee” (last occurring) and substituting “committee”; and
(f) by adding at the end the following sub-section:
“(8) In this section, ‘relevant committee’, in relation to an appeal in relation to a claim, means—
(a) where the claim is in respect of a professional service other than a pathology service—the Medicare Benefits Advisory Committee; and
(b) where the claim is in respect of a pathology service—the Pathology Services Advisory Committee.”.
“16a. (1) A medicare benefit is not payable in respect of a pathology service that has been rendered in relation to a person unless—
(a) the service (whether a pathologist-determinable service or not) was determined to be necessary by a practitioner (in this section referred to as the ‘treating practitioner’) whose patient the person was; or
(b) the service was—
(i) a pathologist-determinable service rendered by or on behalf of an approved pathology practitioner; and
(ii) determined to be necessary by that approved pathology practitioner.
“(2) A medicare benefit is not payable in respect of a pathology service (other than a prescribed pathology service to which sub-section (7) applies) unless—
(a) the service was rendered by or on behalf of an approved pathology practitioner;
(b) the service was rendered in an accredited pathology laboratory and was a service of a kind in respect of which the laboratory was accredited;
(c) the proprietor of the laboratory was an approved pathology authority, or the proprietors of the laboratory were persons each of whom was an approved pathology authority; and
(d) either—
(i) the approved pathology practitioner by whom or on whose behalf the service was rendered was the proprietor, or a proprietor, of the laboratory; or
(ii) the service was rendered in the laboratory under an agreement (whether by way of contract of employment or otherwise) between—
(a) the approved pathology practitioner by whom or on whose behalf the pathology service was rendered; and
(b) the proprietor, or a proprietor, of the laboratory.
“(3) A medicare benefit is not payable in respect of a pathology service (other than a pathologist-determinable service to which sub-section (6) applies) that has been rendered by or on behalf of an approved pathology practitioner unless the service was rendered pursuant to a request made to the approved pathology practitioner by—
(a) the treating practitioner; or
(b) another approved pathology practitioner to whom the treating practitioner has made a request for that service.
“(4) A request to or by an approved pathology practitioner for a pathology service is not effective for the purposes of sub-section (3) unless the request is—
(a) made in writing; or
(b) if made otherwise than in writing—confirmed in writing within the period of 14 days commencing on the day on which the request is made.
“(5) A request to or by an approved pathology practitioner for a pathology service that is made otherwise than in writing and is not confirmed in writing within the period referred to in paragraph (4) (b) shall be deemed, for the purposes of sub-section (3), never to have been made.
“(6) This sub-section applies to a pathology service if the service is a pathologist-determinable service that is rendered by or on behalf of an approved pathology practitioner and the approved pathology practitioner determines that the service is necessary.
“(7) This sub-section applies to a pathology service if the service is a prescribed pathology service that is rendered by or on behalf of a medical practitioner (not being an approved pathology practitioner) and—
(a) the medical practitioner by whom or on whose behalf the service is rendered is the treating practitioner; or
(b) the medical practitioner by whom or on whose behalf the service is rendered—
(i) is a member of a group of practitioners of which the treating practitioner is a member; and
(ii) is requested by the treating practitioner to render the service.
“(8) Where—
(a) a pathology service is rendered by or on behalf of an approved pathology practitioner (in this sub-section referred to as the ‘rendering pathologist’) in an accredited pathology laboratory;
(b) the rendering pathologist is not the proprietor, or a proprietor, of the laboratory; and
(c) the treating practitioner, or an approved pathology practitioner (in this sub-section referred to as the ‘referring pathologist’), made a request for that service to an approved pathology authority who is the proprietor, or a proprietor, of the laboratory,
the treating practitioner or the referring pathologist, as the case may be, shall be deemed, for the purposes of sub-section (3), to have made the request to the rendering pathologist.
“(9) Where—
(a) a practitioner conducts a medical practice or a dental practice; and
(b) another practitioner, or other practitioners, participate (whether as employees or otherwise) in the provision of professional services as part of that practice,
the practitioner referred to in paragraph (a) and the practitioner or practitioners referred to in paragraph (b) shall be taken, for the purposes of this section, to constitute a group of practitioners.
“(10) Where 2 or more practitioners conduct a medical practice or a dental practice as partners, those practitioners and any other practitioner who participates (whether as an employee or otherwise) in the provision of professional services as part of that practice, shall be taken, for the purposes of this section, to constitute a group of practitioners.
“(11) For the purposes of sub-section (10), where 2 or more practitioners share amongst them all the income, or a substantial part of the income, from providing professional services, those practitioners shall be deemed to conduct a practice of providing those professional services as partners.
“(12) In this section—
(a) a reference to a request made in writing or to a confirmation in writing of a request shall be read as including a reference to a request or a confirmation, as the case may be, in such other form as the Minister approves, in writing, from time to time; and
(b) a reference to determining that a service is necessary is a reference to determining that a service is reasonably necessary for the adequate medical care of the patient concerned.
“(13) This section does not apply in relation to a service in relation to which section 21 applies.”.
“(2) Regulations shall not be made for the purposes of sub-section (1) except in accordance with a recommendation made to the Minister by—
(a) in the case of regulations in relation to professional services other than pathology services—the Medicare Benefits Advisory Committee under paragraph 67 (1) (aa); or
(b) in the case of regulations in relation to pathology services—the Pathology Services Advisory Committee under paragraph 78c (1) (b).”.
(a) by inserting in sub-section (2) “(including a pathology service)” after “professional service” (first occurring); and
(b) by adding at the end the following sub-section:
“(3) A medicare benefit is not payable in respect of a pathology service if at the time when the service was rendered, the person by whom or on whose behalf the service was rendered was a person in relation to whom a determination of the kind referred to in subparagraph 124fb (1) (e) (vi) was in effect in respect of that service.
(a) by inserting in sub-section (4) “(other than a pathology service)” after “professional service” (last occurring); and
(b) by inserting after sub-section (4) the following sub-section:
“(4a) Where—
(a) a pathology service is rendered by or on behalf of an approved pathology practitioner; and
(b) the approved pathology practitioner is acting, in relation to the rendering of the pathology service, on behalf of another person,
the pathology service shall be deemed, for the purposes of this section, not to have been rendered on behalf of that other person.”.
“23da. (1) In this Part, unless the contrary intention appears—
‘officer’, in relation to a body corporate, means a director, secretary, manager or employee of the body corporate;
‘relevant offence’ means—
(a) a relevant offence within the meaning of Part Vb;
(b) an offence against sub-section 23dp (1), (2) or (3); or
(c) an offence against—
(i) section 6, 7 or 7aof the
Crimes Act 1914 ;or(ii) sub-section 86 (1) of that Act by virtue of paragraph (a) of that sub-section,
being an offence that relates to an offence against sub-section 23dp (1), (2) or (3);
‘relevant person’ means a person—
(a) to whom notice has been given under sub-section 23dl(1) or 23dm (1) or in relation to whom notice has been given to a Chairperson of a Medicare Participation Review Committee under sub-section 23dl(4), 23dm(4) or 124d(2);
(b) to whom notice has been given under sub-section 124fa (3) or 124fe (3);
(c) in relation to whom a Medicare Participation Review Committee has made a determination under section 124f, 124fb, 124fc or 124ff;
(d) to whom notice has been given under sub-section 95 (1);
(e) in relation to whom a Medical Services Committee of Inquiry has made a recommendation under section 105;
(f) who has been convicted of a relevant offence; or
(g) who the Minister has reasonable grounds to believe may have committed a relevant offence.
“(2) A reference in this Part to a conviction of an offence includes a reference to the making of an order under section 19b of the
“(3) In this Part, ‘prescribed person’ means a person—
(a) in relation to whom a determination under paragraph 124f (2) (d) or (e) or sub-paragraph 124fb (1) (e) (iv), (v) or (vi) or 124fc (1) (e) (iv) or (v) is in force;
(b) who the Minister has reasonable grounds to believe may have committed a relevant offence, being a relevant offence in relation to which a determination has not been made under sub-section 124f (2);
(c) who is a convicted practitioner within the meaning of section 19B as in force before the commencement of Part Vb; or
(d) who the Minister has reasonable grounds to believe may have committed a relevant offence within the meaning of section 19b as in force before the commencement of Part Vb.
“(4) A reference in this Part to disqualification, in relation to a prescribed person is a reference to—
(a) a determination under paragraph 124f (2)(d) or (e) or sub-paragraph 124fb (1) (e) (iv), (v) or (vi) or 124fc(1)(e) (iv) or (v) in relation to the person; or
(b) a disqualification of the person within the meaning of section 19b as in force before the commencement of Part Vb.
“23db. (1) The Minister may approve, in writing, forms of undertaking to be given by persons who wish to become approved pathology practitioners or approved pathology authorities.
“(2) The Minister may vary, in writing, a form of undertaking approved under sub-section (1).
“(3) A form of undertaking shall make provision for and in relation to such matters as the Minister considers appropriate.
“(4) Without limiting the generality of sub-section (3), a form of undertaking to be given by persons who wish to become approved pathology practitioners may make provision for—
(a) an undertaking by the person that pathology services in respect of which medicare benefits may become payable that are rendered on behalf of the person shall be carried out under the person’s personal supervision;
(b) an undertaking by the person not to render excessive pathology services; and
(c) an undertaking by the person that pathology services in respect of which medicare benefits may become payable that are rendered by or on behalf of the person in an accredited pathology laboratory of which the person is not the proprietor or a proprietor shall not be rendered pursuant to agreements or arrangements of a kind specified in the undertaking.
“(5) Sections 48, 49, 49aand 50 of the
“(6) Approvals under sub-section (1) and variations under sub-section (2) shall not be taken to be statutory rules within the meaning of the
“(7) For the purposes of the application of sub-section 5 (3b) of the
“(8) Section 5 of the
“23dc. (1) Where a person who is a medical practitioner—
(a) signs an undertaking in writing for the purposes of this section, in accordance with the appropriate approved form; and
(b) gives the undertaking to the Minister together with—
(i) an application for the Minister’s acceptance of the undertaking; and
(ii) a fee of $100 or such higher amount as is prescribed, the Minister may, subject to sub-sections (3), (4) and (5)—
(c) accept the undertaking on behalf of the Commonwealth and determine the period (being a period ending not later than 12 months after the day on which the undertaking comes into force) for which the undertaking is to have effect; or
(d) refuse to accept the undertaking.
“(2) An application under sub-section (1) shall—
(a) be in writing;
(b) be in accordance with the approved form; and
(c) contain such particulars as are determined by the Minister, in writing, for the purposes of this sub-section.
“(3) The Minister shall not accept an undertaking given by a person for the purposes of this section if a determination of the kind referred to in sub-paragraph 124fb (1) (e) (v) is in force in respect of the person.
“(4) The Minister shall not accept an undertaking given by a person for the purposes of this section if the Minister is satisfied that—
(a) if the undertaking were accepted, the person who gave the undertaking would be likely to carry on the whole or a part of the practice or business of a prescribed person; and
(b) the acceptance of the undertaking would be likely to have the effect of allowing a person to avoid, in whole or in part, the financial consequences of the disqualification, or the likely disqualification, of that prescribed person
“(5) The Minister shall not accept an undertaking given by a person for the purposes of this section unless the Minister is satisfied that the person is a fit and proper person to be an approved pathology practitioner.
“(6) In determining, for the purposes of sub-section (5), whether a person is a fit and proper person to be an approved pathology practitioner, the Minister shall have regard to—
(a) the person’s formal qualifications and experience;
(b) whether the person is a relevant person;
(c) where a Medicare Participation Review Committee has made a determination in relation to the person under section 124f, 124fb, 124fc or 124ff—the terms of that determination;
(d) where a Medical Services Committee of Inquiry has made a recommendation in relation to the person under section 105—the terms of that recommendation;
(e) in a case where the person conducts, or intends to conduct, a practice or business of rendering pathology services—
(i) the persons who derive, or can reasonably be expected to derive, whether directly or indirectly, financial benefit from the conduct of that practice or business; and
(ii) whether any of those persons is a relevant person;
(f) in a case where the person renders, or intends to render, pathology services as the employee of another person—whether that other person is a relevant person;
(g) whether the person is or has been—
(i) associated with a relevant person; or
(ii) in a position to control the operations of a body corporate that—
(a) is, or has been, an approved pathology authority; and
(b) is a relevant person;
(h) such matters as are prescribed for the purposes of this paragraph; and
(j) such other matters as the Minister considers relevant.
“(7) Where a person gives an undertaking under sub-section (1), the Minister may, by notice in writing given to the person, require the person to give the Minister, within such period (being a period ending not earlier than 28 days after the day on which the notice is given) as is specified in the notice, such information in relation to the undertaking, or the application that accompanied the undertaking, as is specified in the notice.
“(8) Without limiting the generality of sub-section (1), where—
(a) the Minister gives a person notice under sub-section (7) in relation to an undertaking given by the person under sub-section (1); and
(b) the person does not give the Minister the information specified in the notice before the end of the period specified in the notice,
the Minister may refuse to accept the undertaking.
“(9) Where the Minister accepts or refuses to accept an undertaking given under sub-section (1), the Minister shall give notice in writing of the acceptance or refusal to the person who gave the undertaking.
“(10) Where the Minister accepts an undertaking given by a person under sub-section (1), the notice given to the person under sub-section (9) shall—
(a) specify the period determined by the Minister, pursuant to paragraph (1) (c), as the period for which the undertaking is to have effect; and
(b) include a statement to the effect that, subject to the
Administrative Appeals Tribunal Act 1975, application may be made to the Administrative Appeals Tribunal for review of the decision of the Minister determining the period for which the undertaking is to have effect by or on behalf of a person whose interests are affected by the decision.
“(11) Where the Minister refuses to accept an undertaking given by a person under sub-section (1), the notice given to the person under sub-section (9) shall include—
(a) a statement to the effect that the person may apply to the Minister under sub-section 23do (1) for reconsideration of the decision of the Minister refusing to accept the undertaking; and
(b) a statement to the effect that if a person whose interests are affected by the decision of the Minister on the reconsideration is dissatisfied with that decision, that person may, subject to the
Administrative Appeals Tribunal Act 1975 ,apply to the Administrative Appeals Tribunal for review of that decision.
“(12) Sections 48, 49, 49aand 50 of the
“(13) Determinations shall not be taken to be statutory rules within the meaning of the
“(14) For the purposes of the application of sub-section 5 (3b) of the
“(15) Section 5 of the
“(16) Any failure to comply with the requirements of sub-section (10) or (11) in relation to a decision does not affect the validity of the decision.
“(17) In sub-section (1), ‘medical practitioner’ includes a person (other than a medical practitioner) who, immediately before 1 August 1977, was carrying on the business of rendering pathology services at the request of medical practitioners, where—
(a) in accordance with an approval granted by the Secretary to the Department, that person issued to the person who incurred the medical expenses in respect of a pathology service so rendered (not being the practitioner who requested the rendering of the service) an account or receipt of his or her fees in respect of the service; and
(b) medical benefit was paid before that day in respect of the service.
“23dd.(1) Where a person gives an undertaking under sub-section 23dc (1) and the Minister accepts the undertaking, the undertaking—
(a) subject to sub-section (2), comes into force—
(i) on the day on which the undertaking is accepted by the Minister; or
(ii) on such earlier day (not being a day earlier than the day on which the undertaking was signed) as is specified by the Minister in the notice given under sub-section 23dc(9) in relation to the undertaking; and
(b) subject to sub-section (3), ceases to be in force upon—
(i) the termination of the undertaking under section 23de;
(ii) the revocation of the Minister’s acceptance of the undertaking in accordance with a determination by a Medicare Participation Review Committee under section 124fb;
(iii) in a case where the person was a medical practitioner at the time when the Minister accepted the undertaking—a person’s ceasing to be a medical practitioner; or
(iv) the expiration of the period determined by the Minister, pursuant to paragraph 23dc (1) (c) or 23do (2) (b), as the period for which the undertaking is to have effect,
whichever first occurs.
“(2) Where—
(a) a person gives an undertaking (in this sub-section referred to as the ‘second undertaking’) under sub-section 23dc (1) and the second undertaking is accepted by the Minister; and
(b) at the time when the second undertaking is accepted by the Minister, another undertaking (in this sub-section referred to as the ‘first undertaking’) given by the person for the purposes of section 23dc and accepted by the Minister under that section is in force,
the second undertaking comes into force immediately after the first undertaking ceases to be in force.
“(3) Where—
(a) a person gives an undertaking (in this sub-section referred to as the ‘first undertaking’) under sub-section 23dc (1) and the first undertaking is accepted by the Minister;
(b) while the first undertaking is in force, the person gives another undertaking (in this sub-section referred to as the ‘second undertaking’) under sub-section 23dc (1); and
(c) the period referred to in sub-paragraph (1) (b) (iv) in relation to the first undertaking expires without the Minister having given the person notice under sub-section 23dc (9) in relation to the second undertaking,
sub-section (1) applies in relation to the first undertaking as if the period referred to in sub-paragraph (1) (b) (iv) were the period commencing on the day on which the first undertaking comes into force and ending on the day on which the Minister gives notice to the person under sub-section 23dc (9) in relation to the second undertaking.
“23de. An approved pathology practitioner may, at any time, terminate an undertaking given by the practitioner for the purposes of section 23dc by giving, as prescribed, a notice of termination specifying a date of termination not earlier than 30 days after the day on which the notice is given.
“23df. (1) Where—
(a) an undertaking for the purposes of this section, in accordance with the appropriate approved form, is signed by or on behalf of a person (including a State, the Northern Territory or a public authority); and
(b) the person gives the undertaking to the Minister together with—
(i) an application for the Minister’s acceptance of the undertaking; and
(ii) a fee of $100 or such higher amount as is prescribed,
the Minister may, subject to sub-sections (4), (5) and (6)—
(c) accept the undertaking on behalf of the Commonwealth and determine the period (being a period ending not later than 12 months after the day on which the undertaking comes into force) for which the undertaking is to have effect; or
(d) refuse to accept the undertaking.
“(2) An application under sub-section (1) shall—
(a) be in writing;
(b) be in accordance with the approved form; and
(c) contain such particulars as are determined by the Minister, in writing, for the purposes of this sub-section.
“(3) Without limiting the generality of sub-section (2), a determination prescribing the particulars to be contained in an application for the purposes of that sub-section may, in the case of an application by a body corporate, prescribe particulars of the directors, shareholders and officers of the body corporate.
“(4) The Minister shall not accept an undertaking given by a person for the purposes of this section if a determination by a Medicare Participation Review Committee of the kind referred to in sub-paragraph 124fc (1) (e) (v) is in force in respect of the person.
“(5) The Minister shall not accept an undertaking given by a person for the purposes of this section if the Minister is satisfied that—
(a) if the undertaking were accepted, the person who gave the undertaking would be likely to carry on the whole or a part of the practice or business of a prescribed person; and
(b) the acceptance of the undertaking would be likely to have the effect of allowing a person to avoid, in whole or in part, the financial consequences of the disqualification, or the likely disqualification, of that prescribed person.
“(6) The Minister shall not accept an undertaking given by a person for the purposes of this section unless the Minister is satisfied that the person is a fit and proper person to be an approved pathology authority.
“(7) In determining, for the purposes of sub-section (6), whether a person is a fit and proper person to be an approved pathology authority, the Minister shall have regard to—
(a) whether the person is a relevant person;
(b) where a Medicare Participation Review Committee has made a determination in relation to the person under section 124f, 124fb, 124fc or 124ff—the terms of that determination;
(c) where a Medical Services Committee of Inquiry has made a recommendation in relation to the person under section 105—the terms of that recommendation;
(d) in a case where the person conducts, or intends to conduct, a business of rendering pathology services—
(i) the persons who derive, or who can reasonably be expected to derive, whether directly or indirectly, financial benefit from the conduct of that business; and
(ii) whether any of those persons is a relevant person;
(e) whether the person is or has been—
(i) associated with a relevant person; or
(ii) in a position to control the operations of a body corporate that—
(a) is, or has been, an approved pathology authority; and
(b) is a relevant person;
(f) in a case where the person is a body corporate—whether any officer of the body corporate, or any person who is in a position to control the body corporate, is or has been—
(i) associated with a relevant person; or
(ii) in a position to control the operations of a body corporate that—
(a) is, or has been, an approved pathology authority; and
(b) is a relevant person;
(g) such matters as are prescribed for the purposes of this paragraph; and
(h) such other matters as the Minister considers relevant.
“(8) Where a person gives an undertaking under sub-section (1), the Minister may, by notice in writing given to the person, require the person to give the Minister, within such period (being a period ending not earlier than 28 days after the day on which the notice is given) as is specified in the notice, such information in relation to the undertaking, or the application that accompanied the undertaking, as is specified in the notice.
“(9) Without limiting the generality of sub-section (1), where—
(a) the Minister gives a person notice under sub-section (8) in relation to an undertaking given by the person under sub-section (1); and
(b) the person does not give the Minister the information specified in the notice before the end of the period specified in the notice,
the Minister may refuse to accept the undertaking.
“(10) Where the Minister accepts or refuses to accept an undertaking given under sub-section (1), the Minister shall give notice in writing of the acceptance or refusal to the person who gave the undertaking.
“(11) Where the Minister accepts an undertaking given by a person under sub-section (1), the notice given to the person under sub-section (10) shall—
(a) specify the period determined by the Minister, pursuant to paragraph (1) (c), as the period for which the undertaking is to have effect; and
(b) include a statement to the effect that, subject to the
Administrative Appeals Tribunal Act 1975, application may be made to the Administrative Appeals Tribunal for review of the decision of the Minister determining the period for which the undertaking is to have effect by or on behalf of a person whose interests are affected by the decision.
“(12) Where the Minister refuses to accept an undertaking given by a person under sub-section (1), the notice given to the person under sub-section (10) shall include—
(a) a statement to the effect that the person may apply to the Minister under sub-section 23do (1) for reconsideration of the decision of the Minister refusing to accept the undertaking; and
(b) a statement to the effect that if a person whose interests are affected by the decision of the Minister on the reconsideration is dissatisfied with that decision, that person may, subject to the
Administrative Appeals Tribunal Act 1975, apply to the Administrative Appeals Tribunal for review of that decision.
“(13) Sections 48, 49, 49aand 50 of the
“(14) Determinations shall not be taken to be statutory rules within the meaning of the
“(15) For the purposes of the application of sub-section 5 (3b) of the
“(16) Section 5 of the
“(17) Any failure to comply with the requirements of sub-section (11) or (12) in relation to a decision does not affect the validity of the decision.
“(18) In this section, ‘public authority’ means an authority (being a corporation) established by a law of the Commonwealth, of a State or of an internal Territory.
“23dg. (1) Where a person gives an undertaking under sub-section 23df (1) and the Minister accepts the undertaking, the undertaking—
(a) subject to sub-section (2), comes into force—
(i) on the day on which the undertaking is accepted by the Minister; or
(ii) on such earlier day (not being a day earlier than the day on which the undertaking was signed) as is specified by the Minister in the notice given under sub-section 23df (10) in relation to the undertaking; and
(b) subject to sub-section (3), ceases to be in force upon—
(i) the termination of the undertaking by the person under section 23dh;
(ii) the revocation of the Minister’s acceptance of the undertaking in accordance with a determination by a Medicare Participation Review Committee under section 124fc; or
(iii) the expiration of the period determined by the Minister, pursuant to paragraph 23df (1) (c) or 23do (2) (b), as the period for which the undertaking is to have effect,
whichever first occurs.
“(2) Where—
(a) a person gives an undertaking (in this sub-section referred to as the ‘second undertaking’) under sub-section 23df (1) and the second undertaking is accepted by the Minister; and
(b) at the time when the second undertaking is accepted by the Minister, another undertaking (in this sub-section referred to as the ‘first undertaking’) given by the person for the purposes of section 23df and accepted by the Minister under that section is in force,
the second undertaking comes into force immediately after the first undertaking ceases to be in force.
“(3) Where—
(a) a person gives an undertaking (in this sub-section referred to as the ‘first undertaking’) under sub-section 23df (1) and the first undertaking is accepted by the Minister;
(b) while the first undertaking is in force, the person gives another undertaking (in this sub-section referred to as the ‘second undertaking’) under sub-section 23df (1); and
(c) the period referred to in sub-paragraph (1) (b) (iii) in relation to the first undertaking expires without the Minister having given the person notice under sub-section 23df (10) in relation to the second undertaking,
sub-section (1) applies in relation to the first undertaking as if the period referred to in sub-paragraph (1) (b) (iii) were the period commencing on the day on which the first undertaking comes into force and ending on the
day on which the Minister gives notice to the person under sub-section 23df (10) in relation to the second undertaking.
“23dh. An approved pathology authority may, at any time, terminate an undertaking given by the authority for the purposes of section 23df by giving, as prescribed, a notice of termination specifying a date of termination not earlier than 30 days after the day on which the notice is given.
“23dj. Where a person gives an undertaking under sub-section 23dc (1) or 23df (1) together with a fee and the undertaking is not accepted, the fee shall be repaid to the person in accordance with the regulations.
“23dk. (1) Where a pathology service has been rendered by or on behalf of an approved pathology practitioner pursuant to a request made or confirmed in accordance with section 16a, the approved pathology practitioner shall retain the written request or the written confirmation of the request for the period of 18 months commencing on the day on which the service was rendered.
“(2) Where—
(a) a request is made to an approved pathology practitioner (in this sub-section referred to as the ‘relevant pathologist’) for a pathology service or pathology services in relation to a person by the practitioner who is the treating practitioner in relation to the person for the purposes of section 16a;
(b) the request is in writing or is confirmed in writing; and
(c) the relevant pathologist makes a request to another approved pathology practitioner for that service, or for a service included in those services, in relation to that person,
the relevant pathologist shall retain the written request or the written confirmation of the request for the period of 18 months commencing on the day on which the request referred to in paragraph (a) is made.
“(3) An approved pathology practitioner shall, if requested to do so by an officer of the Commission, produce to the officer, as soon as practicable and in any case before the end of the day next following the day on which the request is made by the officer, a written request or a written confirmation of a kind required to beretained by the approved pathology practitioner,, under sub-section (1) or (2).
“(4) An officer may make and retain copies of or take and retain extracts from, any request or confirmation produced to the officer pursuant to sub-section (3).
“(5) Where—
(a) a practitioner makes a request for a pathology service to an approved pathology practitioner;
(b) medicare benefit may become payable in respect of the service; and
(c) the request is made otherwise than in writing,
the practitioner shall confirm the request in writing within the period of 14 days commencing on the day on which the request is made.
“(6) Where—
(a) an approved pathology practitioner (in this sub-section referred to as the ‘referring pathologist’) makes a request for a pathology service to another approved pathology practitioner;
(b) medicare benefit may become payable in respect of the service; and
(c) the request is made otherwise than in writing,
the referring pathologist shall confirm the request in writing within the period of 14 days commencing on the day on which the request is made.
“(7) For the purposes of this section, where—
(a) a written request or a written confirmation of a request has been recorded on film or on any other medium approved, in writing, by the Minister from time to time; or
(b) in accordance with an approval, in writing, of the Minister, a request or confirmation (other than a written request or a written confirmation) has been recorded on a tape, disc, film or other medium,
for the purposes of storage and subsequent retrieval when required—
(c) the retention of the record so made shall be deemed to be a retention of the request or the confirmation, as the case may be; and
(d) the production, or the reproduction, of the record so made shall be deemed to be a production of the request or the confirmation, as the case may be.
“(8) Where the Minister gives an approval for the purposes of paragraph (7) (b), the Minister may set out in the instrument of approval any conditions to which the approval is subject, and any recording that is not in accordance with such a condition shall be deemed to be not in accordance with the approval.
“(9) A reference in this section to a request made or confirmed in accordance with section 16a includes a reference to a request made or confirmed in accordance with section 16a of this Act as in force at any time before the commencement of this section.
“(10) A reference in this section to an approved pathology practitioner includes a reference to a person who has been an approved pathology practitioner within the meaning of this Act as in force before the commencement of this section.
“(11) a reference in this section to a request made to an approved pathology practitioner includes a reference to a request that is deemed, for the purposes of section 16a, to have been made to that approved pathology practitioner.
“23dl.(1) Where the Minister has reasonable grounds for believing that a person who is or was an approved pathology practitioner or an approved pathology authority has breached an undertaking given by the person for the purposes of section 23dc or 23df,the Minister shall give notice in writing to the person setting out particulars of those grounds and inviting the person to make submissions to the Minister, in accordance with sub-section (2), showing cause why the Minister should not take further action in relation to the person under this section.
“(2) A person who is given notice under sub-section (1) may, within the period of 28 days commencing on the day on which the notice is given, make submissions to the Minister showing cause why the Minister should not take further action in relation to the person under this section.
“(3) Where a person makes a submission to the Minister in accordance with sub-section (2), the Minister shall have regard to that submission in determining whether to take any further action in relation to the person under this section.
“(4) Where the Minister gives notice to a person under sub-section (1), the Minister shall—
(a) if, at the end of the period referred to in sub-section (2), the person has not made submissions to the Minister in accordance with that sub-section—give notice in writing to a Chairperson of a Medicare Participation Review Committee setting out particulars of the grounds referred to in sub-section (1);
(b) if the person makes submissions to the Minister within the period referred to in sub-section (2) and the Minister is satisfied that there has been no breach of the undertaking—determine that no further action be taken in relation to the person under this section pursuant to the notice referred to in sub-section (1); or
(c) if the person makes submissions to the Minister within the period referred to in sub-section (2) and the Minister is satisfied that there are reasonable grounds (being grounds that were specified in the notice referred to in sub-section (1)) for believing that there has been a breach of the undertaking—give notice in writing to a Chairperson of a Medicare Participation Review Committee setting out particulars of those grounds.
“(5) Where the Minister makes a decision pursuant to sub-section (4) in relation to a person, the Minister shall give the person notice in writing of the decision.
“(6) Where the Minister gives notice pursuant to paragraph (4) (a) or (c) to the Chairperson of a Medicare Participation Review Committee, the Minister may determine, in writing, that the undertaking in respect of which the notice is given be suspended pending the outcome of the proceedings before the Committee.
“(7) Where the Minister makes a determination under sub-section (6) in relation to an undertaking, the undertaking ceases to be in force until—
(a) the determination is revoked by the Minister; or
(b) a Medicare Participation Review Committee makes a determination under section 124fb or 124fcpursuant to the notice referred to in sub-section (6).
“(8) Where the Minister makes a determination under sub-section (6) in relation to an undertaking given by a person, the Minister shall give the person notice in writing of the determination.
“(9) A notice under sub-section (8) shall include a statement to the effect that, subject to the
“(10) Where the Minister makes a determination under sub-section (6) the Minister may, if the Minister thinks fit, publish notice of the determination in the
“(11) An action or proceeding, civil or criminal, does not lie against a person for publishing in good faith a copy of, a fair extract from or a fair abstract of a publication made in accordance with sub-section (10).
“(12) For the purposes of sub-section (11), a publication shall be deemed to be made in good faith if the person by whom it is made is not actuated by ill will to the person affected by the publication or by any other improper motive.
“23dm.(1) Where the Minister has reasonable grounds for believing that—
(a) a person who is or was a practitioner has initiated excessive pathology services;
(b) a person has caused or permitted a practitioner employed by the person to initiate excessive pathology services; or
(c) a person, being an officer of a body corporate, has caused or permitted a practitioner employed by the body corporate to initiate excessive pathology services,
the Minister shall give notice in writing to the person setting out particulars of those grounds and inviting the person to make submissions to the Minister, in accordance with sub-section (2), showing cause why the Minister should not take further action in relation to the person under this section.
“(2) A person who is given notice under sub-section (1) may, within a period of 28 days commencing on the day on which the notice is given, make submissions to the Minister showing cause why the Minister should not take further action in relation to the person under this section.
“(3) Where a person makes a submission to the Minister in accordance with sub-section (2), the Minister shall have regard to that submission in determining whether to take any further action in relation to the person under this section.
“(4) Where the Minister gives notice to a person under sub-section (1), the Minister shall—
(a) if, at the end of the period referred to in sub-section (2), the person has not made submissions to the Minister pursuant to that subsection—give notice in writing to a Chairperson of a Medicare Participation Review Committee setting out particulars of the grounds referred to in sub-section (1);
(b) if the person makes submissions to the Minister within the period referred to in sub-section (2) and the Minister is satisfied that there are no reasonable grounds for believing that the person has initiated excessive pathology services, or caused or permitted excessive pathology services to be initiated as referred to in the notice under sub-section (1), as the case requires—determine that no further action be taken in relation to the person under this section in relation to the notice referred to in sub-section (1); or
(c) if the person makes submissions to the Minister within the period referred to in sub-section (2) and the Minister is satisfied that there are reasonable grounds (being grounds that were specified in the notice referred to in sub-section (1)) for believing that the person has initiated excessive pathology services, or caused or permitted excessive pathology services to be initiated as referred to in that notice, as the case requires—give notice in writing to a Chairperson of a Medicare Participation Review Committee setting out particulars of those grounds.
“(5) Where the Minister makes a decision pursuant to sub-section (4) in relation to a person, the Minister shall give the person notice in writing of the decision.
“23dn.(1) Where a person—
(a) makes an application, in writing, in accordance with the approved form, to the Minister for the approval of premises as an accredited pathology laboratory; and
(b) pays the prescribed fee,
the Minister may, in writing, approve the premises, for the purposes of this Act, as an accredited pathology laboratory and, where the Minister gives such approval, the Minister shall specify in the approval—
(c) the kind of pathology services in respect of which the premises are approved for the purposes of this Act; and
(d) the period (being a period ending not later than 3 years after the day on which the approval takes effect) for which the approval is to have effect.
“(2) The Minister may, in writing, determine principles to be applied by the Minister in the exercise of the Minister’s powers under sub-section (1).
“(3) The Minister shall, in exercising the Minister’s powers under sub-section (1) at a particular time, apply the principles determined under sub-section (2) that are in force at that time.
“(4) An approval under sub-section (1)—
(a) takes effect on the day on which the approval is given or on such later day as is specified in the approval; and
(b) ceases to have effect upon—
(i) the revocation of the approval; or
(ii) the expiration of the period specified in the approval as the period for which the approval is to have effect,
whichever first occurs,
“(5) Where the Minister makes a decision under sub-section (1) approving or refusing to approve premises as an accredited pathology laboratory, the Minister shall give notice in writing of the decision to the person who applied for the approval.
“(6) Where the Minister varies or revokes an approval given under sub-section (1) in relation to premises, the Minister shall give notice in writing of the variation or revocation to the proprietor of the premises.
“(7) A notice under sub-section (5) or (6) shall include a statement to the effect that, subject to the
“(8) Where a person gives an application under sub-section (1) together with a fee and the application is not granted, the fee shall be repaid to the person in accordance with the regulations.
“(9) Sections 48, 49, 49a and 50 of the
regulation were references to a provision of a determination and references to repeal were references to revocation.
“(10) Determinations shall not be taken to be statutory rules within the meaning of the
“(11) For the purposes of the application of sub-section 5 (3b) of the
“(12) Section 5 of the
“23do.(1) Where a person gives an undertaking under sub-section 23dc (1) or 23df(1) and the Minister refuses to accept the undertaking, the person may, within the period of 28 days commencing on the day on which the person is given notice, under sub-section dc(9) or 23df(10), as the case requires, of the Minister’s decision, apply to the Minister for reconsideration by the Minister of the decision.
“(2) Where a person applies to the Minister under sub-section (1) for reconsideration of a decision by the Minister refusing to accept an undertaking given by the person, the Minister may—
(a) affirm the decision; or
(b) accept the undertaking on behalf of the Commonwealth and determine the period (being a period ending not later than 12 months after the day on which the undertaking comes into force) for which the undertaking is to have effect.
“(3) Where the Minister makes a decision under sub-section (2) in relation to an application by a person under sub-section (1), the Minister shall give notice in writing of the decision to the person who applied for the review.
“(4) A notice under sub-section (3) of a decision by the Minister shall include a statement to the effect that, subject to the
“(5) Applications may be made to the Administrative Appeals Tribunal for review of—
(a) a decision by the Minister, under sub-section 23dn (1), approving or refusing to approve premises as an accredited pathology laboratory for the purposes of this Act;
(b) a decision by the Minister varying or revoking an approval given under sub-section 23dn (1);
(c) a decision by the Minister under sub-section (2) of this section;
(d) a decision by the Minister, pursuant to paragraph 23dc (1) (c) or 23df (1) (c), determining the period for which an undertaking is to have effect; or
(e) a decision by the Minister under sub-section 23dl (6) determining that an undertaking be suspended.
“(6) In this section, ‘decision’ has the same meaning as in the
“23dp. (1) An approved pathology practitioner who, without reasonable excuse, contravenes sub-section 23dk (1), (2), (3) or (6) is guilty of an offence punishable, upon conviction, by a fine not exceeding $1,000.
“(2) A practitioner who, without reasonable excuse, contravenes subsection 23dk (5) is guilty of an offence punishable, upon conviction, by a fine not exceeding $1,000.
“(3) An approved pathology practitioner or an approved pathology authority shall not, without reasonable excuse, provide (whether directly or indirectly) to a practitioner a pathology request form that is not in accordance with the approved form.
Penalty: $1,000.
“(4) In this section—
(a) a reference to an approved pathology practitioner includes a reference to a person who has been an approved pathology practitioner;
(b) a reference to an approved pathology authority includes a reference to a person who has been an approved pathology authority; and
(c) a reference to a practitioner includes a reference to a person who has been a practitioner.
“(5) In this section, ‘pathology request form’ means a document for use by a practitioner in requesting pathology services.”.
(a) by inserting in sub-paragraph (1) (a) (i) “of the general medical services table” after “items” (first occurring);
(b) by inserting in sub-paragraph (1) (a) (ii) “of the general medical services table” after “item”;
(c) by inserting in sub-paragraph (1) (a) (ii) “of that table” after “items”;
(d) by inserting in paragraph (1) (aa) “(other than pathology services)” after “professional services”;
(e) by omitting paragraphs (1) (ab) and (ac); and
(f) by inserting in paragraph (1) (b) “(other than a pathology service)” after “professional service”.
“78a. In this Division, unless the contrary intention appears—
‘Chairperson’ means the Chairperson of the Committee, and includes a person acting as Chairperson pursuant to an appointment under section 78j;
‘Committee’ means the Pathology Services Advisory Committee;
‘member’ means a member of the Committee and includes—
(a) the Chairperson; and
(b) a person acting as a member pursuant to an appointment under section 78j.
“78b. There is established by this section a committee by the name of the Pathology Services Advisory Committee.
“78c. (1) The functions of the Committee are—
(a) pursuant to a reference to it by the Minister or on its own initiative, to consider—
(i) in what manner, and to what extent, a particular treatment or combination of treatments should be specified in an item or items of the pathology services table and the appropriate fee or fees that should be specified in that item or those items; or
(ii) whether the scope of, or the amount of the fee set out in, an item of the pathology services table is anomalous, having regard to the other items of that table,
and to make recommendations, in writing, to the Minister arising out of that consideration;
(b) pursuant to a reference to it by the Minister or on its own initiative, to consider whether medicare benefits should continue to be payable in respect of pathology services rendered in particular circumstances, and to make recommendations, in writing, to the Minister arising out of that consideration;
(c) pursuant to a reference to it by the Minister under sub-section 4a(1) or on its own initiative, to consider whether the pathology services table should be varied in accordance with section 4aand, if so, the manner in which it should be so varied, and to make recommendations, in writing, to the Minister arising out of that consideration;
(d) pursuant to a reference to it by the Minister under sub-section 4a(6) or on its own initiative, to consider whether a table should be substituted for the pathology services table in accordance with section 4aand, if so, to make recommendations, in writing, to the Minister arising out of that consideration;
(e) pursuant to a reference to it by the Commission under section 11, to determine whether a fee with respect to a pathology service should be increased for the purposes of a particular claim and, if it is to be so increased, to formulate the principles to be followed in fixing the increased fee, and to make recommendations, in writing, to the Commission accordingly; and
(f) pursuant to a reference to it by the Minister under section 12, to determine whether an appeal under that section should be allowed or dismissed and, if the appeal is to be allowed, to determine the amount of increased fee to be fixed with respect to the service concerned and, if the Committee thinks fit, to formulate the principles followed by the Committee in fixing that increased fee.
“(2) The Minister may, in writing, determine principles to be applied by the Committee in the performance of its functions and the Committee shall perform its functions in accordance with the principles so determined.
“(3) Sections 48, 49, 49aand 50 of the
“(4) Determinations under sub-section (2) shall not be taken to be statutory rules within the meaning of the
“(5) For the purposes of the application of sub-section 5 (3b) of the
Minister of State for Sport, Recreation and Tourism shall be read as a reference to the Minister administering this Act.
“(6) Section 5 of the
“78d. (1) The Committee shall consist of 7 members, namely—
(a) a Chairperson appointed in accordance with sub-section (2);
(b) a member appointed in accordance with sub-section (3);
(c) 2 members appointed in accordance with sub-section (4); and
19.45 | 19.45 | 19.45 | 19.45 | 19.45 | 19.45 | ||
1619 | Cultural examination of material other than blood or urine for aerobic and anaerobic micro-organisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures—examination of material from two or more sites where processed independently (SP) | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 | 45.00 |
1620 | Cultural examination of material other than blood or urine for aerobic and anaerobic micro-organisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures—examination of material from two or more sites where processed independently (OP) | 33.75 | 33.75 | 33.75 | 33.75 | 33.75 | 33.75 |
1622 | Cultural examination for mycobacteria— each specimen (SP) | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1623 | Cultural examination for mycobacteria— each specimen (OP) | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
1633 | Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification-each set of cultures to a maximum of three sets (SP)................ | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 |
1634 | Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification—each set of cultures to a maximum of three sets (OP)............... | 19.45 | 19.45 | 19.45 | 19.45 | 19.45 | 19.45 |
1637 | Screening test for mycoplasma or urea-plasma or both (SP) | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
1638 | Screening test for mycoplasma or urea-plasma or both (OP) | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1640 | Coagulase test for organism identification by slide or tube method, not being a test conducted in conjunction with a service specified in Item 1644, 1647, 1661 or 1664 that is performed for the purpose of identifying the same organism (SP) | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
1641 | Coagulase test for organism identification by slide or tube method, not being a test conducted in conjunction with a service specified in Item 1645, 1648, 1662 or 1665 that is performed for the purpose of identifying the same organism (OP) | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1644 | Identification of pathogenic micro-organisms other than M tuberculosis, using biochemical tests or other special techniques involving sub-culture or biochemical tests and other special techniques involving sub-culture—identification of one organism (SP)........................................ | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1645 | Identification of pathogenic micro-organisms other than M tuberculosis, using biochemical tests or other special techniques involving sub-culture or biochemical tests and other special techniques involving sub-culture—identification of one organism (OP) | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1647 | Identification of two or more organisms, excluding M tuberculosis, by the method referred to in Item 1644 (SP) | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1648 | Identification of two or more organisms, excluding M tuberculosis, by the method referred to in Item 1645 (OP) | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
1661 | Identification of pathogenic micro-organisms using a serological technique (including the immunofluorescent or immunoenxymic method)- a procedure involving one technique (SP) | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1662 | Identification of pathogenic micro-organisms using a serological technique (including the immunofluorescent or immunoenxymic method)- a procedure involving one technique (OP) | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1664 | Two or more of any procedures of a kind referred to in Item 1661 using different............................. | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 |
1665 | Two or more of any procedures of a kind referred to in Item 1662 using different techniques (OP).......... | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
1668 | Anaerobic culture of urine obtained by suprapubic aspiration of the bladder where previous aerobic urine culture is negative, plus microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (not covered by Item 1673, 1674 or 1676) (SP)................................................................. | 32.65 | 32.65 | 32.65 | 32.65 | 32.65 | 32.65 |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
1669 | Anaerobic culture of urine obtained by suprapubic aspiration of the bladder where previous aerobic urine culture is negative, plus microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (not covered by Item 1673, 1674 or 1676) (OP) | 24.50 | 24.50 | 24.50 | 24.50 | 24.50 | 24.50 |
1673 | Microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (other than by simple microscopy and simple culture, e.g. dip slide and microbiological kit tests covered by Item 1682), with sensitivity testing and testing for substances inhibitory to microorganisms where indicated and with general examination for one or more of the following where indicated—pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP)........................................ | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
1674 | Microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (other than by simple microscopy and simple culture, e.g. dip slide and microbiological kit tests covered by Item 1682), with sensitivity testing and testing for substances inhibitory to microorganisms where indicated and with general examination for one or more of the following where indicated—pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (OP)........................................ | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 |
1682 | Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (where the patient is referred by another medical practitioner (SP) | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1683 | Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (where the patient is referred by another medical practitioner (OP). | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1687 | Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (SP)...................................... | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 |
1688 | Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (OP)..................................... | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
1693 | Identification of helminths (SP)............... | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1694 | Identification of helminths (OP).............. | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1702 | Cultural examination for parasites, other than trichomonas—culture of one parasite (SP)................... | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1703 | Cultural examination for parasites, other than trichomonas—culture of one parasite (OP)................... | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
1705 | Cultural examination for parasites, other than trichomonas—culture of two or more parasites (SP).. | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
1706 | Cultural examination for parasites, other than trichomonas—culture of two or more parasites (OP).. | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 |
1721 | Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution—one organism (SP)....... | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1722 | Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution—one organism (OP)...... | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
1724 | Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution—two or more organisms (SP) | 28.50 | 28.50 | 28.50 | 28.50 | 28.50 | 28.50 |
1725 | Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution—two or more organisms (OP) | 21.40 | 21.40 | 21.40 | 21.40 | 21.40 | 21.40 |
1732 | Detection of substances inhibitory to micro-organisms in a body fluid (excluding urine (SP).................... | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
1733 | Detection of substances inhibitory to micro-organisms in a body fluid (excluding urine (SP).................... | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1743 | Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (SP)....... | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1744 | Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (SP)....... | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
1747 | Serological tests for hepatitis—for each test (maximum of 2 tests) (SP)............................................................ | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1748 | Serological tests for hepatitis—for each test (maximum of 2 tests) (OP)............................................................ | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
1756 | Agglutination tests (screening)—one test (SP) | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
1757 | Agglutination tests (screening)—one test (OP) | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1758 | Agglutination tests (screening)—two or more tests (SP) | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
1759 | Agglutination tests (screening)—two or more tests (OP) | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 |
1760 | Agglutination test (quantitative), including those for enteric fever and brucellosis—one antigen (SP)....... | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 |
1761 | Agglutination test (quantitative), including those for enteric fever and brucellosis—one antigen (OP)....... | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
1763 | Agglutination tests (quantitative), including those for enteric fever and brucellosis—second to sixth antigen—each antigen (SP)............................................................ | 9.20 | 9.20 | 9.20 | 9.20 | 9.20 | 9.20 |
1764 | Agglutination tests (quantitative), including those for enteric fever and brucellosis—second to sixth antigen—each antigen (OP)............................................................ | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 |
1766 | Agglutination tests (quantitative), including those for enteric fever and brucellosis—each antigen in excess of six (SP) | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 |
1767 | Agglutination tests (quantitative), including those for enteric fever and brucellosis—each antigen in excess of six (OP) | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 |
1772 | Flocculation test, including V.D.R.L., Kahn, Kline or similar test—one test (SP)............................................. | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
1773 | Flocculation test, including V.D.R.L., Kahn, Kline or similar test—one test (OP)............................................. | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1775 | Flocculation test, including V.D.R.L., Kahn, Kline or similar tests—two or more tests (SP)................ | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 |
1776 | Flocculation test, including V.D.R.L., Kahn, Kline or similar tests—two or more tests (OP)............... | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 |
1781 | Complement fixation tests—one test (SP) | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1782 | Complement fixation tests—one test (OP) | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
1784 | Complement fixation tests—each test in excess of one (SP) | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
1785 | Complement fixation tests—each test in excess of one (OP) | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1793 | Fluorescent serum antibody test (FTA test, FTA—absorbed test or similar)— one test (SP).......................... | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 |
1794 | Fluorescent serum antibody test (FTA test, FTA—absorbed test or similar)— one test (OP)......................... | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
1796 | Each test referred to in Item 1793 in excess of one (SP) | 9.20 | 9.20 | 9.20 | 9.20 | 9.20 | 9.20 |
1797 | Each test referred to in Item 1794 in excess of one (OP) | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 |
1805 | Haemagglutination tests—one test (SP) | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1806 | Haemagglutination tests—one test (OP) | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1808 | Haemagglutination tests—each test in excess of one (SP) | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
1809 | Haemagglutination tests—each test in excess of one (OP) | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1823 | Haemagglutination inhibition tests—one test (SP)... | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1824 | Haemagglutination inhibition tests—one test (OP) | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1826 | Haemagglutination inhibition tests—each test in excess of one (SP).............................................................. | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
1827 | Haemagglutination inhibition tests—each test in excess of one (OP)...................................................... | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1839 | Antistreptolysin O titre or similar test, qualitative, not associated with Item 1843 or 1846 (SP)....... | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
1840 | Antistreptolysin O titre or similar test, qualitative, not associated with Item 1844 or 1847 (OP)........... | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1843 | Antistreptolysin O titre test, antidesoxy-ribonuclease B titre test or similar test (quantitative)—one test (SP) | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 |
1844 | Antistreptolysin O titre test, antidesoxy-ribonuclease B titre test or similar test (quantitative)—one test (OP) | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
1846 | Antistreptolysin O titre test, antidesoxy-ribonuclease B titre test or similar test (quantitative)—two or more tests (SP) | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 |
1847 | Antistreptolysin O titre test, antidesoxy-ribonuclease B titre test or similar test (quantitative)—two or more tests (OP) | 19.50 | 19.50 | 19.50 | 19.50 | 19.50 | 19.50 |
1851 | Total and differential cell count on any body fluid (SP) | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1852 | Total and differential cell count on any body fluid (OP) | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1858 | Autogenous vaccine, preparation of—each organism (SP) | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 |
1859 | Autogenous vaccine, preparation of—each organism (OP) | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 |
1877 | Immunoelectrophoresis using polyvalent antisera (SP) | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 |
1878 | Immunoelectrophoresis using polyvalent antisera (OP) | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 |
1884 | Immunoelectrophoresis using monovalent antiserum—each antiserum (SP).................................... | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
1885 | Immunoelectrophoresis using monovalent antiserum—each antiserum (OP)................................... | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1888 | Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method—estimation of one immunoglobulin (SP)........................ | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1889 | Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method—estimation of one immunoglobulin (OP)....................... | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
1891 | Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method—estimation of each immunoglobulin in excess of one (SP) | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1892 | Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method—estimation of each immunoglobulin in excess of one (OP) | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1897 | Immunoglobulin E, quantitative estimation of (SP) | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 |
1898 | Immunoglobulin E, quantitative estimation of (OP) | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 |
1903 | Radioallergosorbent tests for allergen identification—identification of one allergen (SP).. | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1904 | Radioallergosorbent tests for allergen identification—identification of one allergen (OP). | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1905 | Radioallergosorbent tests for allergen identification—identification of each allergen referred to in Item 1903 in excess of one allergen to a maximum of three allergens (SP) | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 | 5.70 |
1906 | Radioallergosorbent tests for allergen identification—identification of each allergen referred to in Item 1904 in excess of one allergen to a maximum of three allergens (OP) | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
1911 | Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1918), detection of one antibody (SP).............................. | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1912 | Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1919), detection of one antibody (OP)............................. | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
1913 | Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1918), detection of each antibody in excess of one (SP)............. | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1914 | Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1919), detection of each antibody in excess of one (OP) | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1918 | Immunufluorescent detection of tissue antibodies, qualitative and quantitative—detection and estimation of each antibody (SP).............................................................. | 28.50 | 28.50 | 28.50 | 28.50 | 28.50 | 28.50 |
1919 | Immunofluorescent detection of tissue antibodies, qualitative and quantitative—detection and estimation of each antibody (OP).............................................................. | 21.40 | 21.40 | 21.40 | 21.40 | 21.40 | 21.40 |
1924 | Complement fixation tests on human tissue antibodies—one antibody (SP) | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
1925 | Complement fixation tests on human tissue antibodies—one antibody (OP) | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
1926 | Complement fixation tests on human tissue antibodies—each antibody in excess of one (SP)........ | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1927 | Complement fixation tests on human tissue antibodies—each antibody in excess of one (OP)........ | 8.55 | ,8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1935 | Latex flocculation test—qualitative, quantitative or qualitative and quantitative (SP)................................ | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1936 | Latex flocculation test—qualitative, quantitative or qualitative and quantitave (OP).................................. | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1941 | Rose Waaler test, quantitative, using sheep cells (SP) | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1942 | Rose Waaler test, quantitative, using sheep cells (OP) | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
1943 | Modified Rose Waaler test using stabilised sheep cells, not associated with Item 1941 (SP)....... | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1944 | Modified Rose Waaler test using stabilised sheep cells, not associated with Item 1942 (OP)...... | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1948 | Lupus erythematosus cells, preparation and examination of film for (SP)................................................ | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 |
1949 | Lupus erythematosus cells, preparation and examination of film for (OP)................................................ | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
1955 | Tanned erythrocyte haemagglutination test for tissue antibodies—one antibody (SP)....... | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
1956 | Tanned erythrocyte haemagglutination test for tissue antibodies—one antibody (OP)....... | ||||||
17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | ||
1957 | Tanned erythrocyte haemagglutination test for tissue antibodies—each antibody in excess of one (SP)............. | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
1958 | Tanned erythrocyte haemagglutination test for tissue antibodies—each antibody in excess of one (OP) | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
1965 | Leucocyte fractionation as preliminary test to specific tests of leucocyte function—by density gradient centrifugation or any other method (SP).............................. | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 |
1966 | Leucocyte fractionation as preliminary test to specific tests of leucocyte function—by density gradient centrifugation or any other method (OP)............................. | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 |
1971 | Neutrophil or monocyte tests for phagocytic activity—visual techniques (SP) | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 |
1972 | Neutrophil or monocyte tests for phagocytic activity—visual techniques (OP) | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 |
1973 | Neutrophil or monocyte function tests for phagocytic activity—radioactive techniques (SP).............. | 57.00 | 57.00 | 57.00 | 57.00 | 57.00 | 57.00 |
Item No. | Pathology Service | Fees | ||||||
N.S.W | Vic. | Qld | S.A. | W.A. | Tas. | |||
$ | $ | $ | $ | $ | $ | |||
1974 | Neutrophil or monocyte function tests for phagocytic activity—radioactive techniques (OP)................. | 42.75 | 42.75 | 42.75 | 42.75 | 42.75 | 42.75 | |
1981 | Lymphocyte cell count—E. rosette technique or similar (SP) | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | |
1982 | Lymphocyte cell count—E. rosette technique or similar (OP) | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | |
1987 | B lymphocyte cell count—by immunofluorescence or immunoperoxidase (SP) | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | |
1988 | B lymphocyte cell count—by immunofluorescence or immunoperoxidase (OP) | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | |
1995 | Lymphocyte function test—visual trans-formation (SP) | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | |
1996 | Lymphocyte function test—visual transformation (OP) | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | |
1997 | Lymphocyte function test—radioactive techniques (SP) | 69.00 | 69.00 | 69.00 | 69.00 | 69.00 | 69.00 | |
1998 | Lymphocyte function test—radioactive techniques (OP) | 51.75 | 51.75 | 51.75 | 51.75 | 51.75 | 51.75 | |
2006 | Tissue group typing (HLA phenotyping) (SP) | 57.00 | 57.00 | 57.00 | 57.00 | 57.00 | 57.00 | |
2007 | Tissue group typing (HLA phenotyping) (OP) | 42.75 | 42.75 | 42.75 | 42.75 | 42.75 | 42.75 | |
2013 | Mantoux, Schick, casoni or similar test, not being a test covered by Item 987 or 989 (SP)........................ | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | |
2014 | Mantoux, Schick, casoni or similar test, not being a test covered by Item 987 or 989 (OP)....................... | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | |
2022 | Skin sensitivity—induction and detection of sensitivity to chemical antigens (SP) | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | |
2023 | Skin sensitivity—induction and detection of sensitivity to chemical antigens (OP) | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | |
2041 | Histopathology examination of biopsy material—processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (SP) | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 | |
2042 | Histopathology examination of biopsy material—processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (OP) | 60.00 | 60.00 | 60.00 | 60.00 | 60.00 | 60.00 | |
2048 | Immediate frozen section diagnosis of biopsy material performed at the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP) | 104.00 | 104.00 | 104.00 | 104.00 | 104.00 | 104.00 | |
2049 | Immediate frozen section diagnosis of biopsy material performed at the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP) | 78.00 | 78.00 | 78.00 | 78.00 | 78.00 | 78.00 | |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
2056 | Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP).................................................................. | 148.00 | 148.00 | 148.00 | 148.00 | 148.00 | 148.00 |
2057 | Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP).......................................................... | 111.00 | 111.00 | 111.00 | 111.00 | 111.00 | 111.00 |
2060 | Immunofluorescent or immunoperoxidase investigation of biopsy specimen, including any other histopathology examination of the biopsy specimen and any histopathology examination of tissue obtained from the patient at the time the tissue subject to immunofluorescent or immunoperoxidase investigation was obtained—one or both investigations (SP)............................. | 104.00 | 104.00 | 104.00 | 104.00 | 104.00 | 104.00 |
2061 | Immunofluorescent or immunoperoxidase investigation of biopsy specimen, including any other histopathology examination of the biopsy specimen and any histopathology examination of tissue obtained from the patient at the time the tissue subject to immunofluorescent or immunoperoxidase investigation was obtained—one or both investigations (OP)............................. | 78.00 | 78.00 | 78.00 | 78.00 | 78.00 | 78.00 |
2062 | Electron microscopy examination of biopsy specimen, including any other histopathology examination of the biopsy specimen and any histopathology examination of tissue obtained from the patient at the time the tissue subject to the electron microscopy examination was obtained (SP).......... | 120.00 | 120.00 | 120.00 | 120.00 | 120.00 | 120.00 |
2063 | Electron microscopy examination of biopsy specimen, including any other histopathology examination of the biopsy specimen and any histopathology examination of tissue obtained from the patient at the time the tissue subject to the electron microscopy examination was obtained (OP).......... | 90.00 | 90.00 | 90.00 | 90.00 | 90.00 | 90.00 |
2081 | Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane, excluding nasal smears for cell count covered by Item 1545, 1546, 1548 or 1549—each examination (SP) | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
2082 | Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane, excluding nasal smears for cell count covered by Item 1545, 1546, 1548 or 1549—each examination (OP)............ | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
2091 | Cytological examination of body fluid or washings for malignant cells—examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid, any similar fluid, gastric washings, duodenal washings, oesophageal washings or colonic washings, including collection of specimen—each examination (SP)..... | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 |
2092 | Cytological examination of body fluid or washings for malignant cells—examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid, any similar fluid, gastric washings, duodenal washings, oesophageal washings or colonic washings, including collection of specimen—each examination (OP).... | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 |
2093 | Cytological examination for malignant cells of material obtained by fine needle aspiration of solid tissues (SP) | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 |
2094 | Cytological examination for malignant cells of material obtained by fine needle aspiration of solid tissues (OP) | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 |
2104 | Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP) | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 |
2105 | Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP) | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
2111 | Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP)........... | 28.50 | 28.50 | 28.50 | 28.50 | 28.50 | 28.50 |
2112 | Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP)........... | 21.40 | 21.40 | 21.40 | 21.40 | 21.40 | 21.40 |
2148 | Chromosome studies, including preparation, count and karyotyping of amniotic fluid (SP)..... | 172.00 | 172.00 | 172.00 | 172.00 | 172.00 | 172.00 |
2149 | Chromosome studies, including preparation, count and karyotyping of amniotic fluid (OP)..... | 129.00 | 129.00 | 129.00 | 129.00 | 129.00 | 129.00 |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
2155 | Chromosome studies, including preparation, count and karyotyping of bone marrow (SP)... | 114.00 | 114.00 | 114.00 | 114.00 | 114.00 | 114.00 |
2156 | Chromosome studies, including preparation, count and karyotyping of bone marrow (OP).. | 85.50 | 85.50 | 85.50 | 85.50 | 85.50 | 85.50 |
2161 | Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in Item 2148 or 2155—each study (SP) | 138.00 | 138.00 | 138.00 | 138.00 | 138.00 | 138.00 |
2162 | Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in Item 2149 or 2156—each study (OP) | 103.50 | 103.50 | 103.50 | 103.50 | 103.50 | 103.50 |
2170 | Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—one method (SP)....................................................... | 114.00 | 114.00 | 114.00 | 114.00 | 114.00 | 114.00 |
2171 | Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—one method (OP)...................................................... | 85.50 | 85.50 | 85.50 | 85.50 | 85.50 | 85.50 |
2173 | Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—two or more methods (SP)....................................... | 172.00 | 172.00 | 172.00 | 172.00 | 172.00 | 172.00 |
2174 | Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—two or more methods (OP)...................................... | 129.00 | 129.00 | 129.00 | 129.00 | 129.00 | 129.00 |
2201 | Examination of semen for presence of spermatozoa (SP) | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 |
2202 | Examination of semen for presence of spermatozoa (OP) | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 |
2211 | Huhner’s test (post-coital test)—collection of sample and examination of wet preparation (SP) | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
2212 | Huhner’s test (post-coital test)—collection of sample and examination of wet preparation (OP) | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
2215 | Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (SP) | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 |
2216 | Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (OP) | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 |
2225 | Chemical analysis of semen—analysis of one substance (SP) | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 |
2226 | Chemical analysis of semen—analysis of one substance (OP) | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
Item No. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
2227 | Chemical analysis of semen—analysis of two or more substances (SP)................................................................ | 28.50 | 28.50 | 28.50 | 28.50 | 28.50 | 28.50 |
2228 | Chemical analysis of semen—analysis of two or more substances (OP)................................................................ | 21.40 | 21.40 | 21.40 | 21.40 | 21.40 | 21.40 |
2247 | Spermagglutinating and immobilising antibodies, test for—one test (SP)......................................................... | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 | 17.20 |
2248 | Spermagglutinating and immobilising antibodies, test for—one test (OP)........................................................ | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
2249 | Two or more tests referred to in Item 2247 (SP) | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
2250 | Two or more tests referred to in Item 2248 (OP) | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
2264 | Sperm penetrability, one or more tests for—not associated with Item 2211 (SP)............................................... | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
2265 | Sperm penetrability, one or more tests for—not associated with Item 2212 (OP).............................................. | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 | 17.25 |
2272 | Chorionic gonadotrophin (beta-HCG), qualitative estimation or quantitative estimation or qualitative and quantitative estimation by one or more methods for any purpose not covered by Item 2285 or 2286 (SP)............................................... | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 | 11.40 |
2273 | Chorionic gonadotrophin (beta-HCG), qualitative estimation or quantitative estimation or qualitative and quantitative estimation by one or more methods for any purpose not covered by Item 2285 or 2286 (OP).............................................. | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
2285 | Chorionic gonadotrophin quantitative estimation of (including serial dilutions) for assessments of hormone levels in the case of proven hormone producing neoplasms by one or more methods (SP) | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 | 34.50 |
2286 | Chorionic gonadotrophin quantitative estimation of (including serial dilutions) for assessments of hormone levels in the case of proven hormone producing neoplasms by one or more methods (OP)................................................................ | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 |
2287 | Pregnancy pathology assessment—comprising haemoglobin estimation, calculation of red cell indices, blood film examination, blood grouping, examination for blood group antibodies, test for syphilis, test for rubella antibodies, microscopic examination of urine and culture—one assessment in any one pregnancy (SP)................................................................ | 72.00 | 72.00 | 72.00 | 72.00 | 72.00 | 72.00 |
2288 | Pregnancy pathology assessment—comprising haemoglobin estimation, calculation of red cell indices, blood film examination, blood grouping, examination for blood group antibodies, test for syphilis, test for rubella antibodies, microscopic examination of urine and culture—one assessment in any one pregnancy (OP)................................................................ | 54.00 | 54.00 | 54.00 | 54.00 | 54.00 | 54.00 |
ItemNo. | Pathology Service | Fees | |||||
N.S.W. | Vic. | Qld | S.A. | W.A. | Tas. | ||
$ | $ | $ | $ | $ | $ | ||
2294 | Pathology examination of any body fluid or tissue not covered by any other item in this Part (SP)................. | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 |
2295 | Pathology examination of any body fluid or tissue not covered by any other item in this Part (OP)................ | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 |
2334 | Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count—one procedure | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 |
2335 | Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haemato-crit estimation or erythrocyte count—two procedures......................................... | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 |
2336 | Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count—three or more procedures | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 |
2342 | Microscopical examination of urine | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 |
2346 | Pregnancy test by one or more immunochemical methods | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
2352 | Microscopical examination of wet film other than urine | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 |
2357 | Microscopical examination of gram stained film | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 | 6.90 |
2362 | Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method................................ | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 |
2369 | Microscopical examination screening for fungi in skin, hair or nails—one or more sites.................................. | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 |
2374 | Mantoux test........................................... | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
2382 | Casoni test for hydatid disease............. | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
2388 | Schick test................................................ | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 | 8.55 |
2392 | Seminal examination for presence of spermatozoa | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 | 5.20 |
Section 53
MINOR AMENDMENTS OF HEALTH INSURANCE ACT 1973
The following provisions of the
Sub-sections 52 (1), (2), (5) and (7), 53 (3) and 59 (1), (2) and (3), section 64, section 65 (definitions of “Chairman” and “Deputy Chairman”), sub-sections 68 (1), (2), (5) and (7), section 69, sub-sections 70 (3) and 75 (1), (2), (3) and (4), section 78, sub-section 79 (1) (definitions of “Chairman” and “Deputy Chairman”), sub-sections 83 (1), (2), (5) and (7), section 84, sub-sections 85 (2) and 90 (1), (2), (3) and (4), section 93 and sub-section 97 (2).
MINOR AMENDMENTS OF NATIONAL HEALTH ACT 1953
The following provisions of the
Sub-section 84 (1) (definitions of “Chairman” and “member”), paragraph 98a (2) (a), sub-sections 98a (4), 98bb (1) and (2), 98bc (5), 98e (1), 99a (2) and 99b (1), paragraph 99c (1) (a), sub-sections 99c (2) and 99d (1), (3), (7), (8) and (9), section 118 (definition of “Chairman”) and sub-sections 120 (1) and (2), 124 (2) and (4), 125 (1) and 126 (1).
1. No. 42, 1974, as amended. For previous amendments, see No. 58, 1975; Nos. 59, 91, 101, 109 and 157, 1976; No. 75, 1977; Nos. 36, 89 and 133, 1978; Nos. 53 and 123, 1979; No. 132, 1980; Nos. 118 and 176, 1981; Nos. 49, 80 and 112, 1982; Nos. 54 and 139, 1983; Nos. 15, 46, 63, 120, 135 and 165, 1984; and Nos. 24, 65, 70, 95 and 167, 1985.
2. No. 41, 1974, as amended. For previous amendments, see Nos. 61, 91 and 100, 1976; Nos. 36 and 134, 1978; No. 53, 1979; Nos. 54 and 115, 1983; No. 63, 1984; and Nos. 65 and 167, 1985.
3. No. 95, 1953, as amended. For previous amendments, see No. 68, 1955; Nos. 55 and 95, 1956; No. 92, 1957; No. 68, 1958; No. 72, 1959; No. 16, 1961; No. 82, 1962; No. 77, 1963; No. 37, 1964; Nos. 100 and 146, 1965; No. 44, 1966; Nos. 14 and 100, 1967; No. 100, 1968; No. 102, 1969; No. 41, 1970; No. 85, 1971; No. 114, 1972; Nos. 49 and 202, 1973; No. 37, 1974; Nos. 1, 13 and 93, 1975; Nos. 1, 60, 91, 99, 108, 157 and 177, 1976; Nos. 98 and 100, 1977; Nos. 36, 88, 132 and 189, 1978; Nos. 54, 91 and 122, 1979; Nos. 117 and 131, 1980; Nos. 40, 74, 92, 118, 163 and 176, 1981; Nos. 49, 80 and 112, 1982; Nos. 35, 54 and 139, 1983; Nos. 46, 63, 72, 120, 135 and 165, 1984; and Nos. 24, 53, 65, 70, 95, 127 and 167, 1985.
4. No. 164, 1985.
5. No. 46, 1948, as amended. For previous amendments, see No. 216, 1973; Nos. 135 and 165, 1984; and No. 24, 1985.
[
House of Representatives on 8 May 1986
Senate on 30 May 1986
0
0
0